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Anti-proliferation of MDA-MB-231 Cells by Averrhoa bilimbi Extract is 
Associated with G0/G1 Perturbation and Mitochondria-mediated 
Apoptosis Independent of p53
Abstract
Practiced as folk medicine since ancient times, bilimbi (Averrhoa bilimbi) is commonly 
consumed and widely cultivated in Malaysia. In search for naturally occurring anticancer 
agents, a potential fruit extract was found to exert anticancer properties in vitro without any 
cytotoxic effect on normal cells. This study investigated the anti-proliferative effect and 
underlying cell death pathway induced by bilimbi ethanolic extract on human non-hormone-
dependent breast cancer cell line, MDA-MB-231. Anticancer potential of bilimbi extract was 
conducted by investigating the in vitro growth inhibitory effect, DNA fragmentation, cell cycle 
progression and anti-proliferation assay. Release of caspases, cytochrome c and apoptotic 
proteins were demonstrated to determine the mechanism of cell death pathway. Findings 
revealed that bilimbi inhibited growth of MDA-MB-231 cells through the induction of 
apoptosis mediated by cell cycle arrest at G0/G1 checkpoint. Released of cytochrome c coupled 
with up-regulation of caspase-3/7, caspase-9 and Bax pro-apoptotic proteins in addition to 
down-regulation of dysfunctional p53 and Bcl-2 anti-apoptotic proteins implied that bilimbi 
induced a p53-independent mitochondrial apoptosis pathway in MDA-MB-231. These results 
suggest that bilimbi could induce tumor cell anti-proliferation through apoptosis. As a natural 
product, bilimbi could be a promising anticancer agent and an inexpensive approach to cancer 
chemoprevention strategy.
Introduction
Searching for natural products that have 
therapeutic potential for the treatment of cancer is the 
aim of numerous studies.  Many naturally occurring 
agents and extracts have shown antioxidant and 
chemopreventive potential in a diversity of bioassay 
systems and animal models, having relevance to 
human diseases (Aziz et al., 2003). Hence, much 
attention has been focused on the use of natural 
antioxidants because of the worldwide trend to 
minimize the use of synthetic antioxidants which has 
been restricted due to their carcinogenicity (Ito et 
al., 1983). Bilimbi (Averrhoa bilimbi) is among the 
underutilized fruits commonly consumed and widely 
cultivated throughout the tropics in Malaysia. To date, 
there are limited scientific evidences and scarcity 
of data concerning the impact of bilimbi on cancer. 
Hence, it is worthwhile to investigate its anticancer 
activity. This study was undertaken to investigate the 
cytotoxic and apoptotic activities of bilimbi ethanolic 
extract on human non-hormone-dependent breast 
cancer cell line, MDA-MB-231 and to identify the 
possible mechanism of cell death pathway involved 
in the anticancer activity.
Materials and Methods
Materials
All antibodies for flow cytometry detection of 
apoptosis proteins (p53; Cat. No. MCA1710F, Bax; 
Cat. No. MCA2738, Bcl-2; Cat. No. MCA1550 and 
secondary antibody; Cat. No. STAR70) were from 
AbD Serotec (Kidlington, UK). All reagents used for 
cell culture were from Gibco (NY, USA).
Sample preparation and extraction 
Fresh bilimbi fruit was freeze-dried to obtain fine 
powders and extracted with 80% ethanol at 65°C for 
24 hours (Extraction conditions were determined 
though an optimization study to extract phenolic 
compounds using single-factor experiments). The 
extract was filtered, evaporated and freeze-dried. The 
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solution and made up with the culture medium so that 
the final concentration of the vehicle was not > 1% 
DMSO. These final extracts were filtered through a 
0.45 µm nylon membrane syringe filter before use.
Cell cultures 
MDA-MB-231 (human non-hormone-dependent 
breast cancer cell line; ATCC HTB-26) and Chang 
Liver (human non-malignant cell line; ATCC CCL-
13) were obtained from American Type Culture 
Collection (VA, USA). The cells were cultured in 
RPMI-1640 media supplemented with 10% FBS, 
100 IU/ml penicillin and 100 µg/ml streptomycin and 
incubated in 5% CO2 incubator at 37ºC humidified 
atmosphere in 75 cm2 flasks. Confluent monolayer 
cells were detached using 0.25% (w/v) trypsin-
EDTA. 
MTS assay
Cytotoxic study was performed as described 
according to instructions (CellTiter 96® AQueous 
One Solution Cell Proliferation Assay) (Promega, 
WI, USA). Cells were seeded into 96-well plate 
and treated with extract in various concentrations 
for 72 hours, performed through serial twofold 
dilutions. Cells treated with doxorubicin and culture 
medium (1% DMSO) served as positive control and 
negative control, respectively. Absorbance of colored 
formazan produced was recorded on an ELISA plate 
reader at 490 nm. The concentration which gave 50% 
inhibition of cell growth (IC50) was determined from 
a plotted dose-response curve.
TUNEL assay 
Quantitative determination of DNA fragmentation 
was performed as described according to instructions 
(In Situ Cell Death Detection Kit, Fluorescein) 
(Roche, Mannheim, Germany). MDA-MB-231 cells 
were seeded into 6-well plate and treated with bilimbi 
extract in different concentrations over different 
incubation periods. After incubation, cells were fixed 
and permeabilized prior to incubation with TUNEL 
reaction mixture. Percentage of FITC positively 
stained cells was determined on FACSCaliber flow 
cytometer equipped with 488 nm argon laser light 
source and 525 nm band pass filter and analyzed 
using CellQuest Pro software. Percentage of FITC-
positive stained cells was determined from the single-
parameter histogram.
Cell cycle analysis
Cell cycle distribution was determined according 
to a method as described by Mothanna et al. (2011) 
with slight modification. MDA-MB-231 cells were 
seeded into 6-well plate and treated with bilimbi 
extract in different concentrations over different 
incubation period. After incubation, cells were fixed 
and incubated with RNase A and PI in the dark. Cell 
cycle profile was determined by using FACSCaliber 
flow cytometer equipped with 488 nm argon laser 
light source and 630 nm band pass filter and analyzed 
using CellQuest Pro software. Percentage of cells in 
each phase of the cell cycle was determined from the 
single-parameter histogram.
5-Bromo-2’-deoxyuridine (BrdU) incorporation cell 
proliferation assay
Number of proliferating cells was quantified by 
BrdU incorporation assay as described according 
to instructions (Cell Proliferation ELISA, BrdU 
Colorimetric) (Roche, Mannheim, Germany). MDA-
MB-231 cells were seeded into 96-well plate and 
treated with bilimbi extract in different concentrations 
over different incubation periods. Cells were labeled 
and fixed before the addition of antibody conjugate 
solution. Substrate solution was added and incubated 
until color development was sufficient enough 
for photometric detection. Absorbance of colored 
product was recorded on an ELISA plate reader at 
370 nm and presented as O.D value.
Caspase–8 and –9 assays
Quantitative determination of human caspase-8 
and -9 was performed as described according to 
instructions (Human Caspase-8 Platinum ELISA 
and Human Caspase-9 Platinum ELISA) (Bender 
MedSystems, Vienna, Austria). Both were of the 
same protocol. MDA-MB-231 cells were seeded 
into 6-well plate and treated with bilimbi extract in 
different concentrations over different incubation 
periods. After incubation, cells were lysed and 
diluted before the addition of detection antibody and 
anti-rabbit-IgG-HRP. TMB substrate solution was 
added prior to addition of stop solution. Absorbance 
of colored product was recorded on an ELISA plate 
reader at 450 nm. The concentration of human 
caspase-8 and -9 present was determined from a 
plotted dose-response standard curve.
Caspase–3/7 assay
Quantitative determination of human caspase-3/7 
was performed as described according to instructions 
(Caspase-Glo® 3/7 Assay) (Promega, WI, USA). 
MDA-MB-231 cells were seeded into white-walled 
96-well plate and treated with bilimbi extract in 
different concentrations over different incubation 
periods. Caspase-Glo® 3/7 reagent was added and 
gently mixed. Luminescence was measured in a plate-
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reading GloMaxTM 96 Microplate Luminometer. 
The concentration of human caspase-3/7 present was 
recorded as percentage relative to control.
Cytochrome c assay
Quantitative determination of human cytochrome 
c was performed as described according to instructions 
(Human Cytochrome c Platinum ELISA) (Bender 
MedSystems, Vienna, Austria). MDA-MB-231 cells 
were seeded into 6-well plate and treated with bilimbi 
extract in different concentrations over different 
incubation periods. After incubation, cells were lysed 
and diluted before the addition of Biotin-conjugate 
and Streptavidin-HRP. TMB substrate solution was 
added prior to addition of stop solution. Absorbance 
of colored product was recorded on an ELISA plate 
reader at 450 nm. The concentration of human 
cytochrome c present was determined from a plotted 
dose-response standard curve.
p53, Bax and Bcl-2 proteins expression 
MDA-MB-231 cells were seeded into 6-well 
plate treated with 90 µg/ml of bilimbi extract over 
different incubation periods. After incubation, cells 
were fixed and permeabilized with 1% Triton X-100 
for 10 minutes prior to incubation with antibody. 
Percentage of FITC positively stained cells was 
measured using flow cytometer. The settings for flow 
cytometer acquisition and analysis were performed 
as previously described in TUNEL assay. Cells 
incubated with secondary antibody alone served 
as negative control. Percentage of FITC-positive 
stained cells was determined from the overlaid two 
single-parameter histograms.
Statistical analysis
Data are presented as mean ± standard deviation 
(S.D) from three independent experiments. Statistical 
analysis was done using SPSS for Windows version 
17.0. One-way analysis of variance (ANOVA) with 
Tukey’s test was used to test for differences between 
multiple groups which were considered significant at 
p < 0.05. 
Results and Discussion
Growth inhibition
This study evaluated the cytotoxic effect of bilimbi 
on human non-hormone-dependent breast cancer cell 
line, MDA-MB-231 as well as non-malignant Chang 
Liver cell line. Results showed that bilimbi was able 
to induce cytotoxicity in MDA-MB-231 cells with an 
IC50 values of 90 ± 3.46 µg/ml. On the other hand, 
viability of non-malignant Chang Liver was still 
above 50% even though concentration was increased 
up to 200 µg/ml. Literature has shown that antioxidant 
properties of fruits might be associated with 
anticancer activities (Son et al., 2003). The presence 
of high antioxidant vitamins (vitamin A, C and E) in 
bilimbi could be related to its growth inhibition effect 
(Yan et al., 2013). Comparably, doxorubicin, which 
is a highly toxic cancer chemotherapy drug, was used 
as positive control to assess test validity. Results 
proved that doxorubicin was capable to induce 
cytotoxicity in MDA-MB-231 cells (0.4 ± 0.14 µg/
ml) including non-malignant Chang Liver (0.65 ± 
0.13 µg/ml). The fact that bilimbi displayed only 
selective inhibitory effect against cancer cells without 
affecting normal cells made bilimbi potential as a 
choice for development of cancer chemoprevention 
agent towards targeting breast cancers. The selective 
preference of bilimbi is fundamental as cancer drug 
targeting has been nowadays considered a promising 
strategy in cancer chemotherapy as well. Specific 
targeting of tumor cells serves to enhance therapeutic 
efficacy of cytotoxic drug while at the same time 
reducing organ toxicities (Arafa, 2009).
DNA fragmentation
Identification of apoptotic cells in vitro could be 
affirmed by TUNEL assay. This assay is capable of 
detecting DNA strand breaks that occur prior to the 
nucleus fragmenting (Brien et al., 1997) and may 
serve as a marker of apoptosis rather than necrosis 
(Gorczyca, 1999). Results showed that over time 
and with increasing concentrations, percentage of 
TUNEL positively stained cells increased compared 
with untreated cells; supporting the hypothesis that 
bilimbi induced apoptosis in MDA-MB-231 (Figure 
Figure 1. Effect of bilimbi on DNA fragmentation in MDA-
MB-231. TUNEL positive-stained MDA-MB-231 with no 
treatment and treated with bilimbi at 45, 90 and 135 µg/
ml for 24, 48 and 72 hours. Data are presented as mean ± 
standard deviation of three independent experiments (n = 
3). *p < 0.05 compared to untreated cells
1334  Yan, S. W. and Asmah, R./IFRJ 24(3): 1331-1337
1). Percentage of TUNEL positively stained cells was 
higher at 90 µg/ml compared to 135 µg/ml at 24 and 
48 hours although both were significantly higher than 
untreated cells. This could be due to the possibility 
that cells at different stages of apoptosis might co-
exist at any one time (Su et al., 2015). Since TUNEL 
assay detects DNA breakage that occurs during late 
stage of apoptosis, percentage of TUNEL positively 
stained cells at highest concentration was not highest 
as expected.
Cell cycle analysis
Induction of apoptosis by bilimbi on MDA-
MB-231 was further evidenced in cell cycle analysis. 
Endonucleolytic DNA degradation of apoptotic 
cells that results in the extraction of low molecular 
weight DNA are recognized by their fractional DNA 
content (sub G1 peak, sub-diploid peak) through 
flow cytometry analysis (Gorczyca, 1999). Results 
showed that there were increased of sub G1 area 
in bilimbi-treated MDA-MB-231 with increasing 
concentrations over time (Figure 2a-d). Analysis also 
revealed bilimbi exerted growth inhibitory effects on 
MDA-MB-231 by perturbation at G0/G1 phase of 
the cell cycle. There were reduction of cells observed 
in the S and G2/M phases and accumulation of cells 
at G0/G1 phase upon treatment with bilimbi. Few 
studies also reported that upon induction of apoptosis 
in MDA-MB-231, cells were arrested at G0/G1 phase 
of the cell cycle (El-Sherbiny et al., 2001; Nigam et 
al., 2008; Zhong et al., 2011)
Cell proliferation
Through cell cycle analysis, results showed 
that cells in the S phase decreased gradually 
as concentrations increased over time. S phase 
(synthesis phase) is the part of the cell cycle in 
which DNA is replicated. Hence, a decreased in 
S phase indicates a decrease in DNA replication. 
To confirm anti-proliferative activity of bilimbi 
on MDA-MB-231, cell proliferation assay was 
performed. This assay measures cell proliferation 
by quantitating BrdU incorporated into newly 
synthesized DNA of replicating cells only during 
S phase of the cell cycle. Findings revealed that 
percentage of proliferating cells decreased drastically 
upon induction of apoptosis for 72 hours compared 
to untreated cells (Figure 3). However, proliferating 
cells slightly increased as concentration increased 
to 135 µg/ml at 24 and 48 hours post-treatment. 
These DNA syntheses could be due to DNA repair 
process (McDevitt et al., 1995) as BrdU may also be 
incorporated during DNA synthesis not related to cell 
proliferation, such as normal DNA turnover or DNA 
repair (Nowakowski and Hayes, 2000; Cooper-Kuhn 
and Kuhn, 2002). Proliferating cells at 72 hours post-
treatment was also more than those at 24 and 48 hours 
post-treatment at all concentrations probably because 
many cellular processes can result in the synthesis 
of new DNA without the cell going through mitosis 
(Landgren and Curtis, 2010).
Figure 2. Effect of bilimbi on cell cycle progression of 
MDA-MB-231. (a) Cell cycle profile of MDA-MB-231 
with no treatment for 24, 48 and 72 hours. (b) Cell cycle 
profile of MDA-MB-231 treated with bilimbi at 45 µg/ml 
for 24, 48 and 72 hours. (c) Cell cycle profile of MDA-
MB-231 treated with bilimbi at 90 µg/ml for 24, 48 and 
72 hours. (d) Cell cycle profile of MDA-MB-231 treated 
with bilimbi at 135 µg/ml for 24, 48 and 72 hours. Data 
Figure 3. Effect of bilimbi on cell proliferation of MDA-
MB-231 with no treatment and treated with bilimbi 
at 45, 90 and 135 µg/ml for 24, 48 and 72 hours. Data 
are presented as mean ± standard deviation of three 
independent experiments (n = 3). *p < 0.05 compared to 
untreated cells
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Caspase and cytochrome c expression
To elucidate the apoptotic pathway induced 
by bilimbi, activation of caspase-3/7, -8, -9 and 
cytochrome c was measured.  Results revealed that 
cytochrome c increased considerably with increasing 
concentrations upon treatment with bilimbi on 
MDA-B-231 (Figure 4a). Intrinsic pathway is 
mediated by the release of mitochondrial cytochrome 
c. In some cases, cytochrome c may be released in 
extrinsic pathway as well (Kiechle and Zhang, 2002). 
Consequently, activation of caspases was investigated 
in order to determine the apoptotic pathway 
induced by bilimbi on MDA-MB-231. Results 
showed a concentration-dependent up-regulation of 
caspase-3/7 (Figure 4b) and caspase-9 (Figure 4c) 
expression, respectively in bilimbi-treated MDA-
MB-231 compared to untreated cells. However, there 
was no significant (p > 0.05) increased in caspase-8 
(Figure 4d) activity in all concentrations compared to 
untreated cells, indicating that treatment with bilimbi 
induced apoptosis via mitochondria-mediated 
intrinsic pathway in MDA-MB-231. 
Expression of pro- and anti-apoptotic proteins
Data showed that treatment of bilimbi on MDA-
MB-231 slightly down-regulated the expression 
of p53 protein (Figure 5). This could be due to the 
fact that MDA-MB-231 possesses mutant p53. 
Accordingly, p53 is the most widely mutated gene in 
human tumorigenesis (Wang and Harris, 1997; Noa et 
al., 2011) and it is mutated in over 50% of all human 
cancers (Hollstein et al., 1991; Chiarugi et al., 1994; 
Toshinori and Akira, 2011). Induction of apoptosis is 
also partly mediated, intracellularly by Bax and Bcl-
2 (Chiarugi et al., 1994). These two proteins play a 
major role in determining whether cells will undergo 
apoptosis that promote cell death. Results showed 
that upon treatment with bilimbi, level of Bax was 
up-regulated while level of Bcl-2 was slightly down-
regulated in MDA-MB-231. It was in agreement with 
studies reporting that the increased expression of Bax 
can induce apoptosis (Findley et al., 1997; Salomons 
et al., 1997; Wu and Liu, 2015) while Bcl-2 prevents 
cells from apoptosis (Kane et al., 1993; Sano et 
al., 1995; Niture and Jaiswal, 2012). Hence, results 
suggested that induction of apoptosis by bilimbi on 
MDA-MB-231 involved the up-regulation of Bax 
and down-regulation Bcl-2 in a p53-independent 
pathway. 
Conclusion
In summary, the present results provided scientific 
rationale for using bilimbi as a chemopreventive 
or even as therapeutic agent against human breast 
cancer. Findings revealed that bilimbi significantly 
Figure 4. Effect of bilimbi on caspases and cytochrome c 
expression in MDA-MB-231. (a) Cytochrome c release in 
MDA-MB-231 with no treatment and with bilimbi at 45, 
90 and 135 µg/ml for 24, 48 and 72 hours. (b) Caspase-3/7 
expression in MDA-MB-231 with no treatment and with 
bilimbi at 45, 90 and 135 µg/ml for 24, 48 and 72 hours. (c) 
Caspase-9 expression in MDA-MB-231 with no treatment 
and with bilimbi at 45, 90 and 135 µg/ml for 24, 48 and 72 
hours. (d) Caspase-8 expression in MDA-MB-231 with no 
treatment and treated with bilimbi at 45, 90 and 135 µg/
ml for 24, 48 and 72 hours. Data are presented as mean ± 
standard deviation of three independent experiments (n = 
3). *p < 0.05 compared to untreated cells
Figure 5. Effect of bilimbi on pro-apoptotic and anti-
apoptotic proteins expression in MDA-MB-231 treated 
with bilimbi at 90 µg/ml for 0, 24, 48 and 72 hours. 
Data are presented as mean ± standard deviation of three 
independent experiments (n = 3). *p < 0.05 compared to 
0 hour 
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inhibited growth of MDA-MB-231 cells in vitro 
without cytotoxic effect on non-malignant Chang 
Liver cells. Bilimbi cytotoxic activity is likely 
due to the induction of apoptosis mediated by cell 
cycle arrest at G0/G1 checkpoint. Further evidences 
revealed that apoptosis in bilimbi-treated MDA-
MB-231 was initiated by mitochondria independent 
of p53. As a natural product, bilimbi may be a 
promising candidate in search for natural anticancer 
agent.
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